TY - JOUR TI - Improving physical activity in COPD: Towards a new paradigm AU - Troosters, T. AU - Van Der Molen, T. AU - Polkey, M. AU - Rabinovich, R.A. AU - Vogiatzis, I. AU - Weisman, I. AU - Kulich, K. JO - BMJ Open Respiratory Research PY - 2013 VL - 14 TODO - 1 SP - null PB - SN - 2052-4439 TODO - 10.1186/1465-9921-14-115 TODO - bronchodilating agent; budesonide plus formoterol; tiotropium bromide, body mass; body movement; chronic obstructive lung disease; energy cost; energy expenditure; fitness; health status; hospitalization; human; muscle strength; oxygen consumption; physical activity; physical inactivity; pulmonary rehabilitation; quality of life; questionnaire; review; skeletal muscle; chronic obstructive lung disease; counseling; drug therapy; exercise tolerance; motor activity; pathophysiology; physiology, Counseling; Drug Therapy; Exercise Tolerance; Health Status; Humans; Motor Activity; Pulmonary Disease, Chronic Obstructive TODO - Chronic obstructive pulmonary disease (COPD) is a debilitating disease affecting patients in daily life, both physically and emotionally. Symptoms such as dyspnea and muscle fatigue, lead to exercise intolerance, which, together with behavioral issues, trigger physical inactivity, a key feature of COPD. Physical inactivity is associated with adverse clinical outcomes, including hospitalization and all-cause mortality. Increasing activity levels is crucial for effective management strategies and could lead to improved long-term outcomes. In this review we summarize objective and subjective instruments for evaluating physical activity and focus on interventions such as pulmonary rehabilitation or bronchodilators aimed at increasing activity levels. To date, only limited evidence exists to support the effectiveness of these interventions. We suggest that a multimodal approach comprising pulmonary rehabilitation, pharmacotherapy, and counselling programs aimed at addressing emotional and behavioural aspects of COPD may be an effective way to increase physical activity and improve health status in the long term. © 2013 Troosters et al.; licensee BioMed Central Ltd. ER -